From the 1Departments of Obstetrics and Gynecology and Urology, Loyola University Chicago, Stritch School of Medicine, Maywood, Illinois; the 2Department of Obstetrics and Gynecology, University of Utah School of Medicine, Salt Lake City, Utah; the 3Department of Obstetrics and Gynecology, University of Alabama School of Medicine, Birmingham, Alabama; the 4Department of Obstetrics and Gynecology, University of North Carolina School of Medicine, Chapel Hill, North Carolina; the 5Contraception and Reproductive Health Branch, Center for Population Research, National Institute of Child Health and Human Development, National Institutes of Health, Bethesda, Maryland; the 6Department of Gynecology and Obstetrics, Johns Hopkins University School of Medicine, Baltimore, Maryland; the 7Department of Obstetrics and Gynecology, Baylor College of Medicine, Houston, Texas; the 8Department of Obstetrics and Gynecology, University of Pittsburgh, Pittsburgh, Pennsylvania; and the 9Department of Biostatistics, University of Michigan, Ann Arbor, Michigan.
*For members of the Pelvic Floor Disorders Network, see the Appendix online at www.greenjournal.org/cgi/content/full/112/1/49/DC1.
Supported by grants from the National Institute of Child Health and Human Development (U01 HD41249, U10 HD41268, U10 HD41248, U10 HD41250, U10 HD41261, U10 HD41263, U10 HD41269, and U10 HD41267).
Corresponding author: Linda Brubaker, MD, Loyola University Chicago, 2160 South First Avenue, Maywood, IL 60153; e-mail: [email protected].
Financial Disclosure Dr. Brubaker has received research support and a research consulting fee from Pfizer (New York, NY) and research support from Allergan, Inc. (Irvine, CA). Dr. Richter has received research support and consultant fees from Pfizer. Dr. Visco is a paid surgical proctor and consultant for product/procedure development for Intuitive Surgical (Sunnyvale, CA). The other authors have no potential conflicts to disclose.
